Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson
100%
Mutant Mice
100%
Kinase Inhibitor
100%
Neuroprotective
100%
Leucine-rich Repeat Kinase 2 (LRRK2)
100%
Striatal
100%
Inhibitor Treatment
100%
Astrocytes
40%
Primary Cilia
40%
Cilia
40%
Parkinson's Disease
20%
Activating mutation
20%
Disease-associated
20%
Therapeutic Benefits
20%
2-blocks
20%
Dietary Administration
20%
Hedgehog Signaling
20%
Early Administration
20%
Striatum
20%
Cilia Formation
20%
Postmitotic Neurons
20%
Dopaminergic Neurons
20%
Nigral Dopaminergic Neuron
20%
Pedunculopontine nucleus
20%
Hedgehog
20%
Cholinergic Neurons
20%
MLi-2
20%
Cholinergic Interneurons
20%
Neuroprotective Factors
20%
Neuron Viability
20%
Parvalbumin Interneurons
20%
Neuroscience
Kinase
100%
Neuroprotective Agent
100%
Leucine Rich Repeat Kinase 2
100%
Cholinergic
40%
Astrocyte
40%
Glial Cell Line-Derived Neurotrophic Factor
40%
Dopaminergic Neuron
40%
Primary Cilium
40%
Cilium
40%
Parvalbumin
20%
Parkinson's Disease
20%
Dopaminergic
20%
Striatum
20%
Hedgehog Signaling Pathway
20%
Pedunculopontine Nucleus
20%
Interneuron
20%